Financhill
Buy
66

COO Quote, Financials, Valuation and Earnings

Last price:
$82.62
Seasonality move :
7.74%
Day range:
$82.29 - $83.64
52-week range:
$61.78 - $100.24
Dividend yield:
0%
P/E ratio:
44.06x
P/S ratio:
4.04x
P/B ratio:
1.96x
Volume:
728.5K
Avg. volume:
3.3M
1-year change:
-11.03%
Market cap:
$16.2B
Revenue:
$4.1B
EPS (TTM):
$1.87

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
COO
The Cooper Cos., Inc.
$1.1B $1.11 6.12% 98.42% $90.50
KIDS
OrthoPediatrics Corp.
$62M -$0.26 12.55% -54.72% $24.13
LUCY
Innovative Eyewear, Inc.
$1M -$0.49 73.74% -50.4% $3.00
NXGL
NexGel, Inc.
$3.2M -$0.08 6.54% -22.68% $6.00
PODD
Insulet Corp.
$679M $1.15 28.59% 5.4% $377.72
STAA
STAAR Surgical Co.
$89.4M $0.28 54.33% 39.51% $26.56
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
COO
The Cooper Cos., Inc.
$82.57 $90.50 $16.2B 44.06x $0.01 0% 4.04x
KIDS
OrthoPediatrics Corp.
$17.41 $24.13 $436.6M -- $0.00 0% 1.79x
LUCY
Innovative Eyewear, Inc.
$1.36 $3.00 $7.3M -- $0.00 0% 1.85x
NXGL
NexGel, Inc.
$1.59 $6.00 $12.9M -- $0.00 0% 1.04x
PODD
Insulet Corp.
$288.82 $377.72 $20.3B 83.80x $0.00 0% 8.29x
STAA
STAAR Surgical Co.
$23.63 $26.56 $1.2B 49.73x $0.00 0% 5.09x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
COO
The Cooper Cos., Inc.
25.25% 0.349 20.32% 0.89x
KIDS
OrthoPediatrics Corp.
22.39% -0.034 21.68% 3.39x
LUCY
Innovative Eyewear, Inc.
1.01% 5.608 1.04% 9.17x
NXGL
NexGel, Inc.
38.1% -0.508 15.76% 0.82x
PODD
Insulet Corp.
42.7% 1.380 4.75% 1.89x
STAA
STAAR Surgical Co.
9.96% 0.980 2.95% 4.10x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
COO
The Cooper Cos., Inc.
$601M $140.4M 3.45% 4.56% 13.18% $149.9M
KIDS
OrthoPediatrics Corp.
$40M -$4.9M -10.3% -12.83% -7.95% -$3.4M
LUCY
Innovative Eyewear, Inc.
$244.8K -$1.9M -79.57% -80% -287.5% -$1.5M
NXGL
NexGel, Inc.
$1.2M -$725K -33.25% -51.15% -24.71% -$793K
PODD
Insulet Corp.
$513.5M $117.7M 9.14% 18.92% 16.66% $94.6M
STAA
STAAR Surgical Co.
$76.6M $44.5M -23.38% -25.83% 46.96% $1.8M

The Cooper Cos., Inc. vs. Competitors

  • Which has Higher Returns COO or KIDS?

    OrthoPediatrics Corp. has a net margin of 7.94% compared to The Cooper Cos., Inc.'s net margin of -19.22%. The Cooper Cos., Inc.'s return on equity of 4.56% beat OrthoPediatrics Corp.'s return on equity of -12.83%.

    Company Gross Margin Earnings Per Share Invested Capital
    COO
    The Cooper Cos., Inc.
    56.42% $0.43 $11B
    KIDS
    OrthoPediatrics Corp.
    65.27% -$0.50 $450.1M
  • What do Analysts Say About COO or KIDS?

    The Cooper Cos., Inc. has a consensus price target of $90.50, signalling upside risk potential of 9.6%. On the other hand OrthoPediatrics Corp. has an analysts' consensus of $24.13 which suggests that it could grow by 38.57%. Given that OrthoPediatrics Corp. has higher upside potential than The Cooper Cos., Inc., analysts believe OrthoPediatrics Corp. is more attractive than The Cooper Cos., Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    COO
    The Cooper Cos., Inc.
    6 7 1
    KIDS
    OrthoPediatrics Corp.
    4 1 0
  • Is COO or KIDS More Risky?

    The Cooper Cos., Inc. has a beta of 1.048, which suggesting that the stock is 4.779% more volatile than S&P 500. In comparison OrthoPediatrics Corp. has a beta of 1.062, suggesting its more volatile than the S&P 500 by 6.186%.

  • Which is a Better Dividend Stock COO or KIDS?

    The Cooper Cos., Inc. has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. OrthoPediatrics Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Cos., Inc. pays -- of its earnings as a dividend. OrthoPediatrics Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios COO or KIDS?

    The Cooper Cos., Inc. quarterly revenues are $1.1B, which are larger than OrthoPediatrics Corp. quarterly revenues of $61.3M. The Cooper Cos., Inc.'s net income of $84.6M is higher than OrthoPediatrics Corp.'s net income of -$11.8M. Notably, The Cooper Cos., Inc.'s price-to-earnings ratio is 44.06x while OrthoPediatrics Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Cos., Inc. is 4.04x versus 1.79x for OrthoPediatrics Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    COO
    The Cooper Cos., Inc.
    4.04x 44.06x $1.1B $84.6M
    KIDS
    OrthoPediatrics Corp.
    1.79x -- $61.3M -$11.8M
  • Which has Higher Returns COO or LUCY?

    Innovative Eyewear, Inc. has a net margin of 7.94% compared to The Cooper Cos., Inc.'s net margin of -274.85%. The Cooper Cos., Inc.'s return on equity of 4.56% beat Innovative Eyewear, Inc.'s return on equity of -80%.

    Company Gross Margin Earnings Per Share Invested Capital
    COO
    The Cooper Cos., Inc.
    56.42% $0.43 $11B
    LUCY
    Innovative Eyewear, Inc.
    36.64% -$0.38 $10.4M
  • What do Analysts Say About COO or LUCY?

    The Cooper Cos., Inc. has a consensus price target of $90.50, signalling upside risk potential of 9.6%. On the other hand Innovative Eyewear, Inc. has an analysts' consensus of $3.00 which suggests that it could grow by 120.59%. Given that Innovative Eyewear, Inc. has higher upside potential than The Cooper Cos., Inc., analysts believe Innovative Eyewear, Inc. is more attractive than The Cooper Cos., Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    COO
    The Cooper Cos., Inc.
    6 7 1
    LUCY
    Innovative Eyewear, Inc.
    0 0 0
  • Is COO or LUCY More Risky?

    The Cooper Cos., Inc. has a beta of 1.048, which suggesting that the stock is 4.779% more volatile than S&P 500. In comparison Innovative Eyewear, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock COO or LUCY?

    The Cooper Cos., Inc. has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Innovative Eyewear, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Cos., Inc. pays -- of its earnings as a dividend. Innovative Eyewear, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios COO or LUCY?

    The Cooper Cos., Inc. quarterly revenues are $1.1B, which are larger than Innovative Eyewear, Inc. quarterly revenues of $668.1K. The Cooper Cos., Inc.'s net income of $84.6M is higher than Innovative Eyewear, Inc.'s net income of -$1.8M. Notably, The Cooper Cos., Inc.'s price-to-earnings ratio is 44.06x while Innovative Eyewear, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Cos., Inc. is 4.04x versus 1.85x for Innovative Eyewear, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    COO
    The Cooper Cos., Inc.
    4.04x 44.06x $1.1B $84.6M
    LUCY
    Innovative Eyewear, Inc.
    1.85x -- $668.1K -$1.8M
  • Which has Higher Returns COO or NXGL?

    NexGel, Inc. has a net margin of 7.94% compared to The Cooper Cos., Inc.'s net margin of -22.05%. The Cooper Cos., Inc.'s return on equity of 4.56% beat NexGel, Inc.'s return on equity of -51.15%.

    Company Gross Margin Earnings Per Share Invested Capital
    COO
    The Cooper Cos., Inc.
    56.42% $0.43 $11B
    NXGL
    NexGel, Inc.
    40.93% -$0.08 $8.8M
  • What do Analysts Say About COO or NXGL?

    The Cooper Cos., Inc. has a consensus price target of $90.50, signalling upside risk potential of 9.6%. On the other hand NexGel, Inc. has an analysts' consensus of $6.00 which suggests that it could grow by 277.36%. Given that NexGel, Inc. has higher upside potential than The Cooper Cos., Inc., analysts believe NexGel, Inc. is more attractive than The Cooper Cos., Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    COO
    The Cooper Cos., Inc.
    6 7 1
    NXGL
    NexGel, Inc.
    0 0 0
  • Is COO or NXGL More Risky?

    The Cooper Cos., Inc. has a beta of 1.048, which suggesting that the stock is 4.779% more volatile than S&P 500. In comparison NexGel, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock COO or NXGL?

    The Cooper Cos., Inc. has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. NexGel, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Cos., Inc. pays -- of its earnings as a dividend. NexGel, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios COO or NXGL?

    The Cooper Cos., Inc. quarterly revenues are $1.1B, which are larger than NexGel, Inc. quarterly revenues of $2.9M. The Cooper Cos., Inc.'s net income of $84.6M is higher than NexGel, Inc.'s net income of -$647K. Notably, The Cooper Cos., Inc.'s price-to-earnings ratio is 44.06x while NexGel, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Cos., Inc. is 4.04x versus 1.04x for NexGel, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    COO
    The Cooper Cos., Inc.
    4.04x 44.06x $1.1B $84.6M
    NXGL
    NexGel, Inc.
    1.04x -- $2.9M -$647K
  • Which has Higher Returns COO or PODD?

    Insulet Corp. has a net margin of 7.94% compared to The Cooper Cos., Inc.'s net margin of 12.4%. The Cooper Cos., Inc.'s return on equity of 4.56% beat Insulet Corp.'s return on equity of 18.92%.

    Company Gross Margin Earnings Per Share Invested Capital
    COO
    The Cooper Cos., Inc.
    56.42% $0.43 $11B
    PODD
    Insulet Corp.
    72.7% $1.24 $2.4B
  • What do Analysts Say About COO or PODD?

    The Cooper Cos., Inc. has a consensus price target of $90.50, signalling upside risk potential of 9.6%. On the other hand Insulet Corp. has an analysts' consensus of $377.72 which suggests that it could grow by 30.78%. Given that Insulet Corp. has higher upside potential than The Cooper Cos., Inc., analysts believe Insulet Corp. is more attractive than The Cooper Cos., Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    COO
    The Cooper Cos., Inc.
    6 7 1
    PODD
    Insulet Corp.
    19 2 0
  • Is COO or PODD More Risky?

    The Cooper Cos., Inc. has a beta of 1.048, which suggesting that the stock is 4.779% more volatile than S&P 500. In comparison Insulet Corp. has a beta of 1.374, suggesting its more volatile than the S&P 500 by 37.428%.

  • Which is a Better Dividend Stock COO or PODD?

    The Cooper Cos., Inc. has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Insulet Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Cos., Inc. pays -- of its earnings as a dividend. Insulet Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios COO or PODD?

    The Cooper Cos., Inc. quarterly revenues are $1.1B, which are larger than Insulet Corp. quarterly revenues of $706.3M. The Cooper Cos., Inc.'s net income of $84.6M is lower than Insulet Corp.'s net income of $87.6M. Notably, The Cooper Cos., Inc.'s price-to-earnings ratio is 44.06x while Insulet Corp.'s PE ratio is 83.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Cos., Inc. is 4.04x versus 8.29x for Insulet Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    COO
    The Cooper Cos., Inc.
    4.04x 44.06x $1.1B $84.6M
    PODD
    Insulet Corp.
    8.29x 83.80x $706.3M $87.6M
  • Which has Higher Returns COO or STAA?

    STAAR Surgical Co. has a net margin of 7.94% compared to The Cooper Cos., Inc.'s net margin of 9.38%. The Cooper Cos., Inc.'s return on equity of 4.56% beat STAAR Surgical Co.'s return on equity of -25.83%.

    Company Gross Margin Earnings Per Share Invested Capital
    COO
    The Cooper Cos., Inc.
    56.42% $0.43 $11B
    STAA
    STAAR Surgical Co.
    80.89% $0.18 $392.9M
  • What do Analysts Say About COO or STAA?

    The Cooper Cos., Inc. has a consensus price target of $90.50, signalling upside risk potential of 9.6%. On the other hand STAAR Surgical Co. has an analysts' consensus of $26.56 which suggests that it could grow by 12.41%. Given that STAAR Surgical Co. has higher upside potential than The Cooper Cos., Inc., analysts believe STAAR Surgical Co. is more attractive than The Cooper Cos., Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    COO
    The Cooper Cos., Inc.
    6 7 1
    STAA
    STAAR Surgical Co.
    1 9 0
  • Is COO or STAA More Risky?

    The Cooper Cos., Inc. has a beta of 1.048, which suggesting that the stock is 4.779% more volatile than S&P 500. In comparison STAAR Surgical Co. has a beta of 1.008, suggesting its more volatile than the S&P 500 by 0.806%.

  • Which is a Better Dividend Stock COO or STAA?

    The Cooper Cos., Inc. has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. STAAR Surgical Co. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Cos., Inc. pays -- of its earnings as a dividend. STAAR Surgical Co. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios COO or STAA?

    The Cooper Cos., Inc. quarterly revenues are $1.1B, which are larger than STAAR Surgical Co. quarterly revenues of $94.7M. The Cooper Cos., Inc.'s net income of $84.6M is higher than STAAR Surgical Co.'s net income of $8.9M. Notably, The Cooper Cos., Inc.'s price-to-earnings ratio is 44.06x while STAAR Surgical Co.'s PE ratio is 49.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Cos., Inc. is 4.04x versus 5.09x for STAAR Surgical Co.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    COO
    The Cooper Cos., Inc.
    4.04x 44.06x $1.1B $84.6M
    STAA
    STAAR Surgical Co.
    5.09x 49.73x $94.7M $8.9M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock